Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from RELIEF THERAPEUTICS Holding ( (CH:RLF) ) is now available.
Relief Therapeutics has announced an advancement in the publication date of its 2025 half-year report, moving it forward to August 14, 2025, due to the early completion of the report. This report will include a shareholder update and interim financial statements, potentially impacting stakeholders by providing earlier insights into the company’s financial health and strategic direction.
More about RELIEF THERAPEUTICS Holding
Relief Therapeutics Holding SA is a commercial-stage biopharmaceutical company based in Geneva, focused on developing innovative treatment options for rare and debilitating diseases. The company specializes in drug delivery systems and drug repurposing, with a clinical pipeline targeting rare dermatological, metabolic, and respiratory conditions. Relief has successfully brought several products to market through licensing and distribution partnerships.
YTD Price Performance: -41.81%
Average Trading Volume: 40,537
Technical Sentiment Signal: Sell
Current Market Cap: CHF30.81M
For detailed information about RLF stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money